Finance & Investment (Pharma & Healthcare)


Finance and Investment (Pharma and Healthcare) Market Research Reports Analysis and Trends

The Finance and Investment in Pharma and Healthcare industry gives information on budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also gives information on future growth of buyers and suppliers, e-procurement, opinions and strategies of business decision makers and competitors, business priorities, company type and sizes respectively, market analysis of the pharmaceutical company.

The Key features of Finance and Investment in Pharma and Healthcare industry reports are:  

  • Profits growth and future developments in business structure of pharmaceutical industry.
  • Merger and acquisition activity of Pharma companies.
  • Capital expenditure and change in staff recruitment activity in Pharma companies.
  • Key regions of growth within the company.
  • Key industry threats and opportunities of pharmaceutical industry.
  • Key supplier actions and e-procurement.
  • Annual procurement budgets and change in procurement expenditure.
  • Change in supplier selection and procurement objectives of the company.
  • Costs involved in various pharmaceutical company products.
Publication Single User License (PDF) Price
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa

Date Published: Dec 15 2014
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape South Africa report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in South Africa. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
South Africa Pharmaceutical Market is set to grow at $5.6 Billion in 2020.
 
$1,995.00
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies

$3,295.00
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

Date Published: Dec 1 2014

The Gene Therapy Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Vaccine Partnering Agreements Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Diagnostics Partnering Terms and Agreements

Cancer Diagnostics Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

$2,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

Date Published: Dec 1 2014

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

Summary

$1,995.00
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies.

Description
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

$1,995.00
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

$2,995.00
Pharmaceutical Business Confidence Report Q4 2014

Pharmaceutical Business Confidence Report Q4 2014

Date Published: Nov 29 2014
$1,950.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

Date Published: Nov 28 2014
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Singapore report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
Singapore Pharmaceuticals Market is expected to reach $873 Million in 2020.
 
$1,995.00
Bipolar Disorder Partnering 2009-2014

Bipolar Disorder Partnering 2009-2014

Date Published: Nov 1 2014

The Bipolar Disorder Partnering 2009-2014 report provides understanding and access to the bipolar disorder partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in bipolar disorder partnering deals
Top bipolar disorder deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

$695.00
Novo Nordisk Partnering 2009-2014

Novo Nordisk Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Novo Nordisk and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Novo Nordisk report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Novo Nordisk and its partnering interests and activities over the past five years.

$995.00
Irritable Bowel Syndrome Partnering 2009-2014

Irritable Bowel Syndrome Partnering 2009-2014

Date Published: Nov 1 2014

The Irritable Bowel Syndrome Partnering 2009-2014 report provides understanding and access to the irritable bowel syndrome partnering deals and agreements entered into by the worlds leading healthcare companies

Description
The Irritable Bowel Syndrome Partnering 2009-2014 report provides understanding and access to the irritable bowel syndrome partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00
Aspen Partnering 2009-2014

Aspen Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Aspen and its partnering interests and activities over the past seven years

Description
This report provides all the information you require to better understand Aspen and its partnering interests and activities over the past seven years.

$995.00
Valeant Partnering 2009-2014

Valeant Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Valeant and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Valeant 2005-2014 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Valeant and its partnering interests and activities over the past seven years.

$995.00
HIV Partnering 2009-2014

HIV Partnering 2009-2014

Date Published: Nov 1 2014

The HIV Partnering 2009-2014 report provides understanding and access to the HIV partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in HIV partnering deals
Top HIV deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The HIV Partnering 2009-2014 provides understanding and access to the HIV partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,795.00
Essilor Pharmaceuticals Partnering 2009-2014

Essilor Pharmaceuticals Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Essilor and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Essilor 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Essilor and its partnering interests and activities over the past seven years.

$995.00
Coronary Artery Disease Partnering 2009-2014

Coronary Artery Disease Partnering 2009-2014

Date Published: Nov 1 2014

The Coronary Artery Disease Partnering 2009-2014 report provides understanding and access to the coronary artery disease partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in coronary artery disease partnering deals
Top coronary artery disease deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

$995.00
Biomarker Partnering Terms and Agreements

Biomarker Partnering Terms and Agreements

Date Published: Nov 1 2014

The Biomarker Partnering Terms & Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.

$2,995.00
Idiopathic Pulmonary Fibrosis Partnering 2009-2014

Idiopathic Pulmonary Fibrosis Partnering 2009-2014

Date Published: Nov 1 2014

The Idiopathic Pulmonary Fibrosis Partnering 2009-2014 report provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies

Description
The Idiopathic Pulmonary Fibrosis Partnering 2009-2014 report provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data